These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
301 related articles for article (PubMed ID: 29134827)
141. The role of differentially expressed salivary microRNA in oral squamous cell carcinoma. A systematic review. Al Rawi N; Elmabrouk N; Abu Kou R; Mkadmi S; Rizvi Z; Hamdoon Z Arch Oral Biol; 2021 May; 125():105108. PubMed ID: 33756383 [TBL] [Abstract][Full Text] [Related]
142. Droplet Digital PCR Analysis of Liquid Biopsy Samples Unveils the Diagnostic Role of hsa-miR-133a-3p and hsa-miR-375-3p in Oral Cancer. Crimi S; Falzone L; Gattuso G; Grillo CM; Candido S; Bianchi A; Libra M Biology (Basel); 2020 Nov; 9(11):. PubMed ID: 33172167 [TBL] [Abstract][Full Text] [Related]
143. MicroRNA meta-signature of oral cancer: evidence from a meta-analysis. Zeljic K; Jovanovic I; Jovanovic J; Magic Z; Stankovic A; Supic G Ups J Med Sci; 2018 Mar; 123(1):43-49. PubMed ID: 29482431 [TBL] [Abstract][Full Text] [Related]
144. Salivary Micro-RNA and Oral Squamous Cell Carcinoma: A Systematic Review. Menini M; De Giovanni E; Bagnasco F; Delucchi F; Pera F; Baldi D; Pesce P J Pers Med; 2021 Feb; 11(2):. PubMed ID: 33557138 [TBL] [Abstract][Full Text] [Related]
145. Circulating miR-21 as a Potential Biomarker for the Diagnosis of Oral Cancer: A Systematic Review with Meta-Analysis. Dioguardi M; Caloro GA; Laino L; Alovisi M; Sovereto D; Crincoli V; Aiuto R; Coccia E; Troiano G; Lo Muzio L Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32290144 [TBL] [Abstract][Full Text] [Related]
146. lncRNA-HEIH in serum and exosomes as a potential biomarker in the HCV-related hepatocellular carcinoma. Zhang C; Yang X; Qi Q; Gao Y; Wei Q; Han S Cancer Biomark; 2018 Feb; 21(3):651-659. PubMed ID: 29286922 [TBL] [Abstract][Full Text] [Related]
147. Current applications and challenges of circulating tumor DNA (ctDNA) in squamous cell carcinoma of the head and neck (SCCHN). Galot R; Machiels JH Cancer Treat Rev; 2020 Apr; 85():101992. PubMed ID: 32092618 [TBL] [Abstract][Full Text] [Related]
148. Salivary biomarkers for cancer diagnosis: a meta-analysis. Rapado-González Ó; Martínez-Reglero C; Salgado-Barreira Á; Takkouche B; López-López R; Suárez-Cunqueiro MM; Muinelo-Romay L Ann Med; 2020; 52(3-4):131-144. PubMed ID: 32056455 [No Abstract] [Full Text] [Related]
149. Salivaomics in oral cancer. Aro K; Kaczor-Urbanowicz K; Carreras-Presas CM Curr Opin Otolaryngol Head Neck Surg; 2019 Apr; 27(2):91-97. PubMed ID: 30507690 [TBL] [Abstract][Full Text] [Related]
150. Diagnostic and prognostic potential of tissue and circulating long non-coding RNAs in colorectal tumors. Galamb O; Barták BK; Kalmár A; Nagy ZB; Szigeti KA; Tulassay Z; Igaz P; Molnár B World J Gastroenterol; 2019 Sep; 25(34):5026-5048. PubMed ID: 31558855 [TBL] [Abstract][Full Text] [Related]
151. Human papillomavirus as a driver of head and neck cancers. Sabatini ME; Chiocca S Br J Cancer; 2020 Feb; 122(3):306-314. PubMed ID: 31708575 [TBL] [Abstract][Full Text] [Related]
152. Saliva as a Diagnostic Tool in Oral Squamous Cell Carcinoma - a Systematic Review with Meta Analysis. Hema Shree K; Ramani P; Sherlin H; Sukumaran G; Jeyaraj G; Don KR; Santhanam A; Ramasubramanian A; Sundar R Pathol Oncol Res; 2019 Apr; 25(2):447-453. PubMed ID: 30712193 [TBL] [Abstract][Full Text] [Related]
153. Non-invasive screening of a microRNA-based dysregulation signature in oral cancer and oral potentially malignant disorders. Yap T; Seers C; Koo K; Cheng L; Vella LJ; Hill AF; Reynolds E; Nastri A; Cirillo N; McCullough M Oral Oncol; 2019 Sep; 96():113-120. PubMed ID: 31422202 [TBL] [Abstract][Full Text] [Related]
154. HPV-related oropharyngeal cancer: a review on burden of the disease and opportunities for prevention and early detection. Timbang MR; Sim MW; Bewley AF; Farwell DG; Mantravadi A; Moore MG Hum Vaccin Immunother; 2019; 15(7-8):1920-1928. PubMed ID: 31050595 [TBL] [Abstract][Full Text] [Related]
155. miR-31-5p Is a Potential Circulating Biomarker and Therapeutic Target for Oral Cancer. Lu Z; He Q; Liang J; Li W; Su Q; Chen Z; Wan Q; Zhou X; Cao L; Sun J; Wu Y; Liu L; Wu X; Hou J; Lian K; Wang A Mol Ther Nucleic Acids; 2019 Jun; 16():471-480. PubMed ID: 31051332 [TBL] [Abstract][Full Text] [Related]
156. Salivary protein biomarkers for head and neck cancer. Amenábar JM; Da Silva BM; Punyadeera C Expert Rev Mol Diagn; 2020 Mar; 20(3):305-313. PubMed ID: 31986927 [No Abstract] [Full Text] [Related]
157. Hallmarks of Cancer-Related Newly Prognostic Factors of Oral Squamous Cell Carcinoma. Sasahira T; Kirita T Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30115834 [TBL] [Abstract][Full Text] [Related]
158. Liquid biopsy in head and neck squamous cell carcinoma: circulating tumor cells, circulating tumor DNA, and exosomes. Yang WY; Feng LF; Meng X; Chen R; Xu WH; Hou J; Xu T; Zhang L Expert Rev Mol Diagn; 2020 Dec; 20(12):1213-1227. PubMed ID: 33232189 [No Abstract] [Full Text] [Related]
159. Circulating Non-Coding RNAs in Head and Neck Cancer: Roles in Diagnosis, Prognosis, and Therapy Monitoring. Diez-Fraile A; Ceulaer J; Derpoorter C; Spaas C; Backer T; Lamoral P; Abeloos J; Lammens T Cells; 2020 Dec; 10(1):. PubMed ID: 33396240 [TBL] [Abstract][Full Text] [Related]
160. Rapid Clearance Profile of Plasma Circulating Tumor HPV Type 16 DNA during Chemoradiotherapy Correlates with Disease Control in HPV-Associated Oropharyngeal Cancer. Chera BS; Kumar S; Beaty BT; Marron D; Jefferys S; Green R; Goldman EC; Amdur R; Sheets N; Dagan R; Hayes DN; Weiss J; Grilley-Olson JE; Zanation A; Hackman T; Blumberg JM; Patel S; Weissler M; Tan XM; Parker JS; Mendenhall W; Gupta GP Clin Cancer Res; 2019 Aug; 25(15):4682-4690. PubMed ID: 31088830 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]